Research output per year
Research output per year
Personal profile
Headline
CLINICAL INSTRUCTOR | Dermatology
Fingerprint
Dive into the research topics where Michael Cameron is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Review of the Safety and Efficacy of Deucravacitinib for Plaque Psoriasis: An Expert Consensus Panel
Shah, M., Burshtein, J., Zakria, D., Boh, E., Cameron, M., Glick, B., Golant, A., Han, G., Hsu, S., Lockshin, B., Neimann, A., Rosmarin, D. & Lebwohl, M., Feb 2025, In: Journal of Drugs in Dermatology. 24, 2, p. 147-154 8 p.Research output: Contribution to journal › Review article › peer-review
5 Scopus citations -
Laboratory monitoring in patients with moderate to severe plaque psoriasis
Fenkel, J. M., Osborne, J. A., Armstrong, A. W., Strober, B., Stein Gold, L., Cameron, M. & Lebwohl, M., 2025, In: Journal of Dermatological Treatment. 36, 1, 2583227.Research output: Contribution to journal › Review article › peer-review
Open Access -
The role of interleukin-13 in the management of atopic dermatitis: an expert consensus panel
Debusk, L., Atanaskova-Mesinkovska, N., Bartley, B., Burshtein, J., Cameron, M., Daly, T., Eichenfield, L., Merritt, D., Patel, T., Rigel, D., Rosenberg, A., Shah, M., Swanson, L., Zakria, D. & Lebwohl, M., 9 Aug 2025, In: Dermatology Online Journal. 31, 4, Article 2.Research output: Contribution to journal › Review article › peer-review
Open Access2 Scopus citations -
Tralokinumab as a Therapeutic Alternative for Dupilumab-associated Arthralgia in Atopic Dermatitis: A Multi-center Case Series
Greenberg, A. B. W., Shahriari, M., Cameron, M. C., Payette, M., Dasilva, D. R., Damiani, G., Herman, E. I., Eminger, L. A., Issa, N. T., Rodriguez, A., Del Rosso, J. Q., Kang, Y., Cohen, J. M. & Bunick, C. G., May 2025, In: Journal of Clinical and Aesthetic Dermatology. 18, 5, p. 16-19 4 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Two-Year Treatment Persistence of Guselkumab vs Other Biologics in Plaque Psoriasis Patients
Strober, B. E., Janak, J. C., Fitzgerald, T., Marchese, M., Teneralli, R. E., Rowland, K., Choi, O., Chan, D., Lesser, E., Cameron, M. & Lebwohl, M., Aug 2025, In: Journal of Drugs in Dermatology. 24, 8, p. 762-768.Research output: Contribution to journal › Article › peer-review
2 Scopus citations
Press/Media
-
Bambusa Therapeutics Reports Potentially Transformative Preliminary Proof-of-Concept Results for BBT001 in Atopic Dermatitis, Reinforcing Its Best-in-Disease Potential
27/07/26
22 items of Media coverage
Press/Media
-
U.S. Patents Awarded to Inventors in Connecticut (April 28)
28/04/26
1 item of Media coverage
Press/Media
-
Aclaris Therapeutics trades higher, up 4.2% in Week 11 of 2026: Latest News and Company Communication
23/03/26
1 item of Media coverage
Press/Media
-
Aclaris Therapeutics shares jump 15.7% in Week 10 of 2026: Latest News and Company Communication
16/03/26
1 item of Media coverage
Press/Media
-